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The link between poor maternal nutrition and an increased burden of disease in the 24 
subsequent generations has been widely demonstrated in both human and animal studies. 25 
Historically, the nutritional challenges experienced by pregnant and lactating women were 26 
largely those of insufficient calories and severe micronutrient deficiencies. More recently 27 
however, Western societies have been confronted with a new nutritional challenge; that of 28 
maternal obesity and excessive maternal intake of calories, fat and sugar. The exposure of the 29 
developing fetus and infant to this obesogenic environment results in an increased risk of 30 
obesity and metabolic disease later in life. Furthermore, this increased caloric intake often 31 
occurs in conjunction with micronutrient deficiency, which may further exacerbate these 32 
programming effects. In light of the current epidemic of obesity and metabolic disease, 33 
attention has now turned to identifying nutritional interventions for breaking this 34 
intergenerational obesity cycle. In this review, we discuss the approaches that have been 35 
explored to date, and highlight the need for further research.  36 
Key words: maternal nutrition, pregnancy, fetal programming, obesity, micronutrients  37 
  38 
  39 
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Introduction  40 
A world-wide series of epidemiological and experimental animal studies has provided 41 
compelling evidence that the nutritional environment experienced before birth and early 42 
infancy has a central role in determining the long-term health of individuals (McMillen & 43 
Robinson, 2005). As a result, maintaining an appropriate maternal nutrient supply during 44 
pregnancy and lactation is of central importance for optimising the development of the fetus 45 
and neonate. For the developing fetus and breast-fed infant, the maternal diet is the sole 46 
source of nutrition, and must therefore supply all of the necessary macro- and micro-nutrients 47 
to support the growth and development of tissue and organ systems. As a consequence, 48 
inappropriate maternal nutrition during these critical periods of development has the potential 49 
to impact negatively on the long-term health of the children.  50 
 51 
The importance of maternal nutrition for supporting growth and development has been 52 
recognised for decades. The devastating effects of sub-optimal maternal nutrition  on fetal 53 
and infant growth are perhaps illustrated most clearly by the effects of severe deficiencies of 54 
key micronutrients (Zlotkin 2011). Rickets was once a relatively common childhood disorder 55 
resulting from maternal Vitamin D deficiency, and spina bifida a neural tube disorder is 56 
caused by insufficient maternal folate intake during the critical period of development of the 57 
nervous system in the first trimester of pregnancy (Park, 1940; De Wals et al., 2007; Zlotkin 58 
2011). Recognition of the origin of these disorders led to wide-spread interventions to correct 59 
these deficiencies in the maternal diet and, as a result, these once common disorders have 60 
been virtually eliminated in the developed world (Park, 1940; De Wals et al., 2007).  61 
 62 
Whilst overt maternal nutrient deficiencies are no longer commonplace, modern Western 63 
countries are facing a new nutritional challenge, that of maternal obesity and caloric excess, 64 
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sometimes in conjunction with micronutrient deficiency(Kaidar-Person et al., 2008). The 65 
exposure of individuals to this ‘obeseogenic environment’ before birth and in early infancy 66 
has been shown to increase their propensity to obesity and its associated metabolic disorders 67 
in child and adult life, thereby creating an intergenerational cycle of obesity and metabolic 68 
disease (Catalano, 2003; Catalano & Ehrenberg, 2006; Rkhzay-Jaf et al., 2012). The purpose 69 
of this review is to explore our current understanding of the early life origins of obesity and 70 
to discuss potential nutritional strategies for breaking the intergenerational obesity cycle.  71 
 72 
The Global Epidemic of Obesity and Metabolic Disease 73 
The incidence of obesity and metabolic disease continues to increase across the globe. 74 
According to the most recent figures released by the WHO, the worldwide prevalence of 75 
obesity nearly doubled between 1980 and 2008. In 2008, more than 1.4 billion adults (20 76 
years and older) were overweight and, of these, over 200 million men and nearly 300 million 77 
women were obese (WHO, 2012). The obesity epidemic has extended to the world’s children, 78 
and in 2012 more than 40 million children under the age of five were classified as overweight 79 
(WHO, 2012). In addition to the direct impact of overweight and obesity on physical and 80 
mental health, these conditions are also associated with a number of co-morbidities, in 81 
particular type 2 diabetes (T2DM) and cardiovascular disease, which further reduce the 82 
quality of life of these individuals (Bray, 2004). The rising prevalence of obesity and its 83 
associated metabolic disorders places a considerable economic burden on the health care 84 
budgets of governments in developed and developing countries (Daviglus et al., 2004; WHO, 85 
2012). In this context, there has been a growing recognition of the need to develop effective 86 
strategies for obesity prevention, and attention has turned to the role of the early nutritional 87 
environment as a modulator of obesity risk and a potential window of opportunity for 88 
intervention.  89 
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Maternal Obesity and Overnutrition: A Growing Obstetric Challenge 90 
The obesity epidemic has spread to include women from all age groups, including women of 91 
reproductive age, and this has resulted in a dramatic rise in the number of women entering 92 
pregnancy overweight or obese. In 2000, around 30% of women entering pregnancy in the 93 
US and Australia were classified as overweight or obese (Callaway et al., 2006; Catalano & 94 
Ehrenberg, 2006). More recent figures have suggested that this figure may now be even 95 
higher, and that over 50% of women were overweight or obese when presenting for their first 96 
antenatal appointment (Athukorala et al., 2010; Dodd et al., 2011c). On the basis of these 97 
figures, we would therefore expect that at least half of all infants born in developed countries 98 
are exposed to maternal overweight or obesity before birth.  99 
 100 
This increasing prevalence of maternal overweight and obesity has implications for the long-101 
term health of children. Mothers who are overweight or obese during their pregnancy have an 102 
increased risk of pregnancy complications, caesarean delivery and infant morbidities (Dodd 103 
et al., 2011a). The infants are also more likely to be born at greater than the 90th centile for 104 
their gestational age or macrosomic (>4000g), largely as a result of increased fat deposition 105 
(Catalano, 2003). Importantly, these infants are not only heavier at birth, but go on to be at 106 
increased risk of obesity and type 2 diabetes during childhood and adulthood (Catalano & 107 
Ehrenberg, 2006; Rkhzay-Jaf et al., 2012). This has therefore created an intergenerational 108 
cycle of obesity and metabolic disease, which has been identified in numerous populations 109 
across the globe. More recent studies have attempted to quantify the magnitude of the effect; 110 
population-based studies in both Pima Indians and multi-ethnic populations in the US have 111 
identified maternal obesity and diabetes during pregnancy as the strongest risk factor for the 112 
development of type 2 diabetes in the offspring, accounting for 40% and 47% respectively of 113 
the type 2 diabetes cases in these populations (Dabelea et al., 1998; Dabelea et al., 2008). 114 
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The risk of type 2 diabetes in populations exposed to diabetes in utero remains higher even 115 
when the effects of maternal body fat mass are controlled for, suggesting that there are 116 
independent effects of maternal diabetes and high maternal glucose levels on the systems 117 
which control fat deposition and insulin sensitivity (Dabelea et al., 2008).  118 
 119 
The description of this intergenerational cycle of obesity in human populations world-wide, 120 
has led to the search for the underlying biological mechanisms which drive it and these 121 
studies have implicated maternal nutrition as a critical player. In these studies, maternal 122 
overweight or obesity is associated with increases in the concentrations of key nutrients, in 123 
particular glucose, in the maternal circulation (Catalano et al., 2003). Glucose is the principal 124 
substrate for fetal growth, and is delivered to the fetus down a transplacental glucose gradient 125 
from the maternal circulation (Fowden, 1995). Therefore, increased maternal glucose 126 
concentrations result in an increased delivery of glucose to the developing fetus. This 127 
stimulates insulin production by the fetal pancreas and leads to excess fetal growth and fat 128 
deposition (Metzger, 1991) as well as  increased infant weight at birth (Figure 1). In addition 129 
to the effects on growth, exposure to excess glucose and fat (particularly saturated fat) also 130 
influences gene expression in developing tissues and thereby produce permanent changes in 131 
their structure and function (Armitage et al., 2004).  132 
 133 
The Biological Mechanisms 134 
An increasing number of studies in animal models have attempted to explore the biological 135 
mechanisms through which maternal overweight and overnutrition increase the susceptibility 136 
to obesity in the offspring (Armitage et al., 2004; McMillen et al., 2009). These studies have 137 
provided evidence that exposure to an excess nutrient supply before birth, particularly 138 
glucose and saturated fat, acts on a number of the key systems involved in the regulation of 139 
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appetite, fat deposition and insulin sensitivity, reducing the capacity of an individual to 140 
maintain energy balance and glucose homeostasis in postnatal life. While animal studies have 141 
provided important insights into the biological mechanisms of developmental programming, 142 
there are differences between animals and humans in the timing of organ development, 143 
placental nutrient transfer and maternal/fetal metabolism which need to be considered when 144 
extrapolating these findings to humans. There is also a need to consider how the treatment 145 
applied to the animals relates to the human experience. By way of example, exclusively high-146 
fat diets have been widely used in rodent studies of developmental programming, but are 147 
have been shown to be a less robust model for studying human metabolic disease compared 148 
to the model in which animals are fed a cafeteria diet (Sampey et al., 2011). Whilst it is not 149 
clear whether all the mechanisms identified in animals also operate in humans, the phenotype 150 
of offspring born following maternal nutritional perturbations are comparable between 151 
humans and many different animal models, suggesting that the process of fetal programming 152 
is common to a wide range of species (Ozanne, 2001; Armitage et al., 2004).  153 
 154 
The appetite-regulating neural network is located in the arcuate nucleus of the hypothalamus. 155 
This network has been well-described in a number of species, and consists of neurons which 156 
contain neuropeptides that act to either stimulate (e.g Neuropeptide Y, NPY and Agouti-157 
related peptide, AGRP) or inhibit (e.g. Proopiomelanocortin, POMC and Cocaine-158 
amphetamine regulated transcript, CART) food intake (Williams et al., 2001). The network is 159 
chiefly regulated by the adipocyte-derived hormone, leptin, whose receptor is expressed on 160 
the neurons within the appetite-regulating network. Leptin binding acts to reduce the 161 
expression of appetite-stimulating neuropeptides and increase the expression of appetite-162 
inhibitors, thereby potently reducing feeding behaviour (Williams et al., 2001) (Baskin et al., 163 
2001). The major period of development of this network is before birth (in humans and large 164 
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mammals) and in the early postnatal period (in rats and mice). Importantly, exposure to an 165 
increased nutrient supply during the development of this network results in impaired appetite 166 
regulation in postnatal life (Grove & Smith, 2003) (Muhlhausler et al., 2004). In sheep, lambs 167 
exposed to maternal overnutrition during the second half of pregnancy consume more milk 168 
during the immediate postnatal period and are fatter at one month of age than their control 169 
counterparts (Muhlhausler et al., 2006). Importantly, these lambs are no longer able to 170 
appropriately regulate their appetite in response to an increase in food intake, and this appears 171 
to be a consequence of reduced expression of the leptin receptor in the appetite-regulating 172 
centre (Muhlhausler et al., 2006). Similar dysregulation of appetite and persistent 173 
hyperphagia are also reported in rodent offspring who are born to mothers fed on high-fat, 174 
high-sugar diets during pregnancy and lactation, or exposed to overnutrition as a result of 175 
small-litter rearing in the early postnatal period (Plagemann et al., 1999; Kirk et al., 2009).  176 
 177 
In addition to effects on food intake, there is also evidence that prenatal exposure to high-fat 178 
and high-sugar diets results in alterations to food preferences (Bayol et al., 2007; Teegarden 179 
et al., 2009; Ong & Muhlhausler, 2011). In our laboratory, we have shown that offspring of 180 
rat dams fed a high fat, high sugar cafeteria diet during pregnancy and lactation exhibit an 181 
increased preference for fat compared to offspring of dams fed a standard rodent diet, when 182 
provided with free access to a cafeteria diet after weaning (Ong & Muhlhausler, 2011). 183 
Perinatal exposure to the cafeteria diet was also associated with altered development of the 184 
central reward pathway in the offspring, which could account for the increased propensity 185 
towards overconsumption of palatable foods (Ong & Muhlhausler, 2011).  186 
 187 
In the case of adipose tissue, studies in both rodents and large animal models have reported 188 
that maternal obesity and hyperglycemia are associated with increased mRNA expression 189 
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(Muhlhausler et al., 2007) and activity (Kasser et al., 1981; Benkalfat et al., 2011) of key 190 
lipogenic genes in the adipose tissue of the offspring. These genes include the lipogenic 191 
transcription factor, PPARγ, and lipogenic enzymes, lipoprotein lipase (LPL) and glycerol-3-192 
phosphate dehydrogenase (G3PDH). It is the increased activity of these genes that is 193 
associated with an increased accumulation of adipose tissue in early postnatal life 194 
(Muhlhausler et al., 2006). Furthermore, this increased lipogenic capacity in the adipose 195 
tissue persists beyond the immediate post-natal period, such that these offspring have a 196 
greater capacity for lipid storage throughout the lifecourse.  197 
 198 
Offspring exposed to maternal hyperglycemia or maternal high-fat feeding also exhibit 199 
severely impaired glucose tolerance and insulin sensitivity in young adulthood (Catalano & 200 
Ehrenberg, 2006). Studies in rodents have demonstrated that this is the result of altered 201 
development of key components of the insulin signalling pathway in the offspring; offspring 202 
of obese dams exhibited a decreased abundance of insulin-receptor substrate 1 (IRS1) and 203 
impaired phosphorylation of Protein Kinase B (PKB), in muscle and liver, consistent with 204 
impaired signaling downstream of the insulin receptor (Shelley et al., 2009). The nutritional 205 
environment an individual experiences during the perinatal period therefore plays a critical 206 
role in determining the structure and function of the adipose tissue, liver and skeletal muscle 207 
in postnatal life, and therefore the risk of obesity, glucose intolerance and insulin resistance in 208 
the offspring (Poston et al., 2011). 209 
 210 
Given this, there is good evidence to suggest that exposure to maternal obesity/overnutrition 211 
has substantial impacts on the development of systems regulating energy balance and 212 
metabolism, which have lasting effects on the susceptibility of these individuals to obesity 213 
and metabolic disease later in life (Figure 2). These studies have highlighted the important 214 
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role of maternal nutrition in mediating these effects, and this has led to suggestions that the 215 
adverse effects of maternal obesity/maternal overnutrition during critical windows of 216 
development could potentially be alleviated or corrected by targeted nutritional interventions.  217 
 218 
The Case for Nutritional Interventions 219 
Fetal development is a time during which tissues and organ systems are undergoing rapid and 220 
complex development, and exposure to even small amounts of toxins during critical 221 
developmental windows can have devastating long-term effects. As a result, the use of drugs 222 
either before birth or during early infancy for overcoming the effects of exposure to an 223 
increased nutrient supply is unlikely to be a feasible approach. In contrast, nutritional 224 
interventions are safe, relatively inexpensive and have the potential to be feasibly 225 
implemented on a population level. The efficacy of nutritional interventions during 226 
pregnancy/lactation for producing lasting benefits for the offspring has also been 227 
demonstrated in cases of micronutrient deficiency. Ensuring adequate Vitamin D intake 228 
during pregnancy and lactation in previously deficient individuals resulted in a dramatic 229 
decrease in the incidence of rickets in infants and children (Park, 1940) and the wide-spread 230 
use of folate supplements in early pregnancy has virtually eliminated neural tube defects (De 231 
Wals et al., 2007).  232 
 233 
Interventions which reduce even mildly elevated maternal glucose concentrations have also 234 
been shown to result in marked improvements in pregnancy outcomes studies (Poston, 2011). 235 
In addition to being reported in animal models, the efficacy of nutritional interventions to 236 
reduce maternal glucose has been demonstrated in two large-scale clinical studies, including 237 
the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) and the 238 
Maternal-Fetal Medicine Unit (MFMU) Network study. In both cases, aggressive dietary 239 
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management of mild gestational diabetes, compared to routine care, resulted in reduced risks 240 
of preeclampsia, perinatal morbidity and fetal overgrowth (Crowther et al., 2005; Landon et 241 
al., 2009). The search for nutritional interventions that could overcome the effects of 242 
overnutrition have focussed on either a whole-diet approach to reduce maternal glucose levels 243 
or various single-nutrient approaches. The remaining sections of this review will discuss 244 
some nutritional interventions which have shown early promise, including restricting 245 
gestational weight gain, maintaining a low glycemic index (GI) diet during pregnancy and 246 
targeted maternal nutritional supplements. .  247 
 248 
Potential Strategies for Nutritional Intervention 249 
Global Calorie Restriction  250 
Independent of maternal weight at the start of pregnancy, the degree of weight gained during 251 
pregnancy (gestational weight gain) has been associated with an increased risk of obesity in 252 
the child (Dodd et al., 2011a). The suggested guidelines for maternal weight gain during 253 
pregnancy are lower for women who are overweight or obese, compared to those in the 254 
underweight or healthy weight ranges. However, few overweight and obese women are able 255 
to adhere to these weight gain guidelines, and compliance rates are lower than for normal 256 
weight women (Dodd et al., 2011a). It has therefore been suggested that limiting weight gain 257 
during pregnancy, through diet and life-style interventions, may be an effective strategy for 258 
improving the long-term health outcomes of children born to overweight and obese mothers. 259 
A recent systematic review focusing on the impact of weight-management programs in 260 
pregnant women assessed the results of 88 studies, which were made up of 40 randomised 261 
and 48 non-randomised and observational studies, involving a total of 182,139 women 262 
(Athukorala et al., 2010). The authors of this review concluded that dietary interventions in 263 
pregnancy were the most effective strategy for weight-management. These dietary 264 
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interventions to limit gestational weight gain were associated with significant reductions in 265 
the incidence of pre-eclampsia, gestational hypertension and preterm birth and also tended to 266 
reduce the incidence of gestational diabetes (Athukorala et al., 2010). Importantly, none of 267 
these studies identified significant maternal or fetal adverse effects as a result of these 268 
interventions.  269 
 270 
Despite these encouraging findings, the authors acknowledged that there was considerable 271 
heterogeneity in the effect of the dietary interventions in different studies. They suggested 272 
that thismay have been due to differences in BMI, age, parity, socioeconomic status and 273 
medical conditions in pregnancy between the study populations, as well as differences in 274 
genetic background of the populations under study. In addition, there have been no follow up 275 
studies in humans which have determined whether these nutritional interventions in the 276 
mother have beneficial effects for the later metabolic health of the children. Nevertheless, the 277 
evidence to date suggests that limiting gestational weight gain in overweight and obese 278 
women may be an effective strategy for improving neonatal outcomes in women who enter 279 
pregnancy with a high BMI, and do not appear to carry any significant risks for maternal or 280 
fetal health. It is important to exercise caution with this last statement, since it is clear from 281 
animal studies that restricting maternal caloric intake before or during pregnancy, 282 
independent of maternal BMI, may result in altered development of the HPA axis in the fetus 283 
and result in altered functioning of the stress axis in postnatal life (Zhang et al., 2011). The 284 
scientific community eagerly awaits the results of large scale randomised controlled trials of 285 
limiting weight gain in pregnancy in overweight/obese women, such as the LIMIT study in 286 
South Australia  (Dodd et al., 2011b), in order to provide more robust evidence for the 287 
benefits of diet and lifestyle interventions during pregnancy.  288 
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Low GI diets 289 
The glycemic index (GI) describes the effects of different carbohydrate foods on blood 290 
glucose levels. Carbohydrates that break down quickly during digestion and release glucose 291 
rapidly into the bloodstream have a high GI; whilst carbohydrates that break down more 292 
slowly, releasing glucose gradually into the bloodstream, have a low GI (Brand-Miller & 293 
Holt, 2004; Brand-Miller, 2004). As a result, a low GI diet is associated with lower fasting 294 
and postprandial glucose concentrations than a high GI diets (Brand-Miller, 2004). Low GI 295 
diets have received significant attention in adult nutrition in relation to their effects on body 296 
weight and insulin action. In support of this, switching overweight and/or type 2 diabetic 297 
individuals from typical western (high GI) diets to low GI diets can improve insulin 298 
sensitivity and assist with maintenance of weight loss (Jenkins et al., 2008; Larsen et al.; 299 
Marsh et al.). 300 
 301 
The GI of the diet is likely to be particularly relevant in pregnancy, given that glucose is 302 
transferred directly from the mother to the fetus and is the main energy substrate for 303 
intrauterine growth (Fowden, 1995). Based on previous findings in adults, we and others have 304 
hypothesised that consuming a low GI diet during pregnancy would be associated with 305 
exposure of the fetus to a lower glucose supply compared to a moderate-high GI diet, and 306 
thus to a reduced risk of obesity and type 2 diabetes in the offspring. Whilst there have been 307 
few studies to date which have investigated the effects of low GI diets during pregnancy on 308 
neonatal outcomes, the  results from the small number of existing studies have been 309 
encouraging. Indeed, a recent systematic review of human studies investigating the effect of 310 
maternal intake of low GI diets on pregnancy outcomes reported that four of the eight studies 311 
carried out to date showed a protective association between low GI diets and pregnancy-312 
related outcomes, and none showed negative effects (Louie et al., 2010). These studies 313 
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demonstrated that for both normal and diabetic women birth weight, birth weight z-score and 314 
ponderal index of offspring were lower in women consuming the low GI diet compared to 315 
those consuming a standard Western diet or low-fat diet, and there was a reduced risk of 316 
delivering a large for gestational age or macrosomic infant (Louie et al., 2010; Louie et al., 317 
2011). However, while these studies provide important evidence that lowering the GI of the 318 
diet consumed in pregnancy may be an effective strategy for improving perinatal outcomes, 319 
there are no studies which have evaluated the impact of a low GI diet during pregnancy on 320 
the metabolic health of the offspring beyond the immediate postnatal period. It therefore 321 
remains to be determined whether this intervention will produce lasting health benefits to the 322 
offspring. The added attraction of the low GI diet, in comparison to other diets used for 323 
weight-loss and controlling glucose homeostasis, is the fact that they appear to be more 324 
acceptable for consumers.  325 
 326 
Omega-3 Long Chain Polyunsaturated Fatty Acids (LCPUFA) 327 
The omega-3 long chain polyunsaturated fatty acids (LCPUFA), docosahexaenoic acid 328 
(DHA) and eicosapentaenoic acid (EPA), play an important role in optimal fetal and neonatal 329 
development (Makrides & Gibson, 2002) ). Whilst most studies to date have focussed on 330 
their role in neurodevelopment, there has been increasing interest in their potential metabolic 331 
effects as a result of data from in vitro studies which have shown that both DHA and EPA 332 
can inhibit the proliferation and differentiation of pre-adipocytes and selectively inhibit the 333 
activity of pro-adipogenic factors (Ailhaud et al., 2006; Massiera et al., 2006). In addition, 334 
omega-3 LCPUFA also act on mature adipose cells to inhibit the expression of the key 335 
lipogenic mediator sterol-regulated binding protein 1 (SREBP-1c), resulting in a reduced 336 
expression of downstream lipogenic genes, including Fatty Acid Synthase (FAS) and glycerol 337 
3 phosphate dehydrogenase (G3PDH) and a reduced accumulation of lipid (Masden et al., 338 
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2005). Thus, at least in adults, omega-3 LCPUFAs can reduce the accumulation of body fat 339 
by limiting both the hyperplastic and hypertrophic expansion of adipose depots (Okuno et al., 340 
1997; Raclot et al., 1997; Ruzickova et al., 2004). 341 
 342 
The evidence linking omega-3 LPCUFA with reduced fat deposition, have led us and others 343 
to hypothesise that supplementing the diet of the mother with omega-3 LCPUFA during 344 
pregnancy and/or lactation may be a potential strategy for reducing fat mass, and thereby 345 
improve metabolic outcomes, in their children (Hauner et al., 2009). The studies in this area 346 
to date have, however, produced conflicting and disparate results, and there is still a lack of 347 
robust evidence that exposure to an increased supply of omega-3 fatty acids during early life 348 
has the potential to produce lasting metabolic benefits (Muhlhausler et al., 2010). To date, 349 
only 4 published human studies have investigated this have been relatively small with high 350 
attrition rates and have, perhaps unsurprisingly given these caveats, produced disparate 351 
results (Muhlhausler et al., 2010). Indeed, 2 of these studies reported an increase in fat 352 
accumulation in children who had been exposed to omega-3 supplementation during infancy 353 
(Lauritzen et al., 2005), which is in complete contrast to the hypothesised effect. Whilst 354 
animal studies have more consistently reported a reduction in fat mass in offspring of mothers 355 
receiving a diet supplemented with omega-3 LCPUFA during pregnancy and/or lactation 356 
(Korotkova et al., 2002; Massiera et al., 2003; Wyrwoll et al., 2006; Ibrahim et al., 2009), all 357 
but one of these studies have also weaned the offspring onto a high omega-3 LCPUFA diet. 358 
In our laboratory, we found that offspring of dams supplemented with omega-3 fatty acids 359 
only during pregnancy and lactation, and then weaned onto a standard rodent feed containing 360 
low levels of omega-3 LCPUFA exhibited an increase in relative body fat mass at 6 weeks of 361 
age, which was normalised by 3 months (Muhlhausler et al., 2011). There is therefore still 362 
considerable work to be done in determining whether omega-3 LCPUFA supplementation of 363 
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the maternal diet is an appropriate strategy for curtailing early fat deposition, and if providing 364 
these supplements to overweight and obese mothers could help improve the metabolic 365 
outcomes in their children.  366 
 367 
Maternal Nutritional Supplements 368 
Whilst maternal overnutrition is associated with increased intake of calories, saturated fats 369 
and/or sugars, there is data that has suggested that this global overnutrition can occur against 370 
a background of deficiency in key micronutrients (Kaidar-Person et al., 2008). Therefore, the 371 
potential exists for the negative effects of being exposed to an excess supply of fat and 372 
glucose during development to be compounded by those of being exposed to an inadequate 373 
supply of key micronutrients. The concentrations of micronutrients in the maternal blood, 374 
perhaps with the exception of haemoglobin as an indicator of iron status, are not routinely 375 
assessed during pregnancy (Women’s and Children’s Health Network, (2012 ), making it 376 
difficult to identify the extent of such deficiencies.   377 
 378 
Similar to what has been reported for human diets containing excess amounts of junk foods, 379 
the cafeteria diet that we have used in our rodent model of maternal overfeeding is also 380 
deficient in several key micronutrients, in particular calcium and magnesium (Gugusheff and 381 
Muhlhausler, unpublished observations). This is potentially significant, since maternal 382 
dietary insufficiency of magnesium as well as zinc and iron, even in the absence of maternal 383 
overnutrition, has been associated with an increased risk of obesity and its associated 384 
metabolic disorders in the offspring. In rodents, maternal magnesium  or zinc deficiency are 385 
both associated with increased body fat mass, reduced lean mass and reduced insulin 386 
secretion in the adult offspring (Venu et al., 2005; Venu et al., 2008). Similarly, offspring of 387 
iron deficient mothers exhibit increased visceral adiposity, decreased locomotor activity and 388 
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an increased susceptibility to diet-induced obesity (Komolova et al., 2008; Bourque et al., 389 
2012).  390 
 391 
Clinically, micronutrient deficiencies have been associated with low birth weights. However, 392 
studies in human populations which have investigated the long term metabolic outcomes of 393 
children born to women provided with micronutrient supplements during pregnancy are 394 
limited.  A randomised control trial in Nepalese women and showed that folic acid-iron-zinc 395 
supplementation but not folic acid-iron supplementation, reduced the incidence of low birth 396 
weight by 15%.  Importantly, children of women who received the folic acid-iron-zinc 397 
supplement also had reduced peripheral adiposity 6-8 years of age (Stewart et al., 2009). This 398 
was supported by a similar study in Peruvian women, which also highlighted the benefits of 399 
zinc supplementation in increasing lean body mass in the children in infancy (Iannotti et al., 400 
2008). Whilst it is apparent that further investigations are needed, micronutrient 401 
supplementation during pregnancy could act as an important nutritional intervention to 402 
improve the metabolic outcomes of children born to mothers consuming an energy dense but 403 
nutrient poor western diet. Ideally, these micronutrients would be obtained from the diet, 404 
however nutritional supplements are likely to provide a more practical solution. There are an 405 
increasing number of nutritional supplements specifically targeted at pregnant and lactating 406 
women. However, whether the levels of key micronutrients they contain is sufficient to 407 
overcome deficiencies in women consuming diets dominated by processed and convenience 408 
foods remains to be investigated.  409 
 410 
 411 
Summary and Perspective 412 
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It is now well-established that the nutritional environment that an individual experiences 413 
before birth and in early postnatal life has a critical role in defining the long-term health 414 
outcomes of the offspring. Through most of history, insufficient caloric intake and severe 415 
micronutrient deficiencies were the major problems for women in pregnancy. Whilst these 416 
problems are still, unfortunately, experienced in many parts of the world, in developed 417 
countries it has been largely replaced by a new nutritional challenge; maternal obesity and 418 
overnutrition. Infants exposed to this obeseogenic environment during early life are at 419 
increased risk of obesity and metabolic disease, thereby creating an intergenerational cycle of 420 
poor metabolic health.  421 
 422 
In this review, we have discussed the mechanisms thought to underlie this association, and 423 
some of the potential nutritional strategies through which it may be possible to intervene 424 
(Figure 3). Despite the scale of the obesity problem, there remains a paucity of studies which 425 
have attempted to test these interventions in either animal models or the clinical setting. It is 426 
our view that a greater focus on intervention is essential if we are to break the 427 
intergenerational cycle of the obesity and metabolic disease, and that food may indeed be the 428 
best medicine to address this. It is also important to note the recent data which has 429 
demonstrated that the paternal diet before conception can have independent effects on the 430 
metabolic phenotype of the offspring. Two note-worthy studies in this area have 431 
demonstrated that paternal high-fat feeding (Ng et al., 2010) and low-protein diets (Carone et 432 
al., 2010) are both associated with metabolic programming of the offspring, even when all 433 
mothers are maintained on the same diet during pregnancy and lactation. Thus, when 434 
developing nutritional interventions to overcome the trans-generational obesity cycle, it may 435 
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FIGURE LEGENDS 445 
Figure 1. Proposed pathways through which maternal obesity results in increased fetal 446 
growth. Maternal obesity and/or overnutrition results in increased nutrient delivery to the 447 
developing fetus. This increases fetal glucose concentrations and stimulates the fetal pancreas 448 
to release insulin. The resulting fetal hyperglycemia and hyperinsulinemia promotes tissue 449 
growth and fat deposition, resulting in a heavy infant who is also at risk of obesity and type 2 450 
diabetes (TDM) later in life.  451 
 452 
Figure 2. Summary of the biological mechanisms implicated in the early life origins of 453 
obesity. Exposure of the developing fetus/neonate to an increased nutrient supply results in 454 
altered development of the systems which regulate appetite, motivation and reward, fat 455 
deposition and insulin signalling which results in persistent changes to how these systems 456 
operate in postnatal life and thus prediposes the individual to obesity and metabolic disease. 457 
These effects may be exacerbated by deficiencies of key micronutrients during the 458 
development of these systems. 459 
 460 
Figure 3. Proposed nutritional interventions for overcoming the programming of obesity by 461 
maternal obesity/overnutrition. These strategies focus on either global dietary approaches to 462 
improve maternal glycemic control and thereby reduce glucose delivery to the developing 463 
fetus (diet lifestyle interventions, low GI diets) or targetting specific developmental pathways 464 
using single nutrients (omega-3 LCPUFA, micronutrient supplementation).  465 
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